my resting heart rate is up about 3 bpm, did that settle for anyone
⚠️1
#retatrutide 2024-10-01
Tuesday28 messages8 participantstimes are UTC
Highlights from this day
- private_script_pri — im at 15 and the appetite effect is stronger than i expected, normal 10:37
- LC_MS_Lena — PeptideMeter came back 96.8 on one lot and 97.4 on the next from the same QYB, both fine 11:40
- LC_MS_Lena — the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial 11:47
- gradient_greg — the purity spread across lots worries me more than the molecule does, i could be wrong 12:37
held at 0.5 for 5 months and it never plateaued for me, which i cant explain
blood pressure stayed flat for me while heart rate moved, which i didnt expect
did anyone come off because of the heart rate
😂1
TRIUMPH is phase 3
phase 2 only
i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps
is the glucagon arm what people mean by the energy expenditure thing
im at 15 and the appetite effect is stronger than i expected, normal
weights-monthly.csv
593 rows · not retained in the public archive
back after 3 months, has anything actually been published since
[edited]triple agonist meaning GLP-1, GIP and glucagon, have i got that right
slightly off topic but does the glucagon arm explain the heart rate or is that unrelated
follow up phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan
stepping in 10 increments instead of doubling is the only thing i would change if i started again
research use only
phase 2 was still trending at the end which is why the phase 3 readout matters more than usual
PeptideMeter came back 96.8 on one lot and 97.4 on the next from the same QYB, both fine
anyone logging resting heart rate on this
private_script_prii went up too fast, got a fortnight of nothing but nausea, and dropped back two steps
the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial
🤝16
buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely
stopped for 17 months and restarted at half my old dose, the ramp was easier second time
the purity spread across lots worries me more than the molecule does, i could be wrong
📉4👍1
research use only is on every vial and i treat it as exactly that, nobody here is prescribing
coming back to this nobody should read my log as a plan, im recording what i did and thats all it is
cant feel it honestly
the honest position is this has less human evidence behind it than anything else discussed here
genuine question is the GI worse than tirzepatide or about the same
whats the half life like, is it weekly the same way
triple agonist yeah